XML 25 R8.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statement of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock Outstanding
Treasury Shares at Cost
Par Value and Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance, beginning of period at Dec. 31, 2017 $ 22,559   $ (4) $ 38,629 $ 8 $ (16,074)
Common stock, shares outstanding, beginning (in shares) at Dec. 31, 2017   859,406,651        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 1,453         1,453
Other comprehensive loss 0          
Stock-based compensation 234     234    
Exercise of stock options 3     3    
Exercise of stock options (in shares)   137,541        
Stock issued for employee stock purchase plan 55     55    
Stock issued for employee stock purchase plan (in shares)   1,069,495        
Issuance of vested restricted stock units (in shares)   4,455,559        
Issuance of restricted stock awards (in shares)   354,459        
Shares withheld related to net share settlement of stock awards and stock options (84)     (84)    
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (1,403,806)        
Repurchases of common stock (1,054)     (1,054)    
Repurchases of common stock (in shares)   (16,738,758)        
Transfer RSU to NQDC plan     (3) 3    
Transfer RSU to NQDC plan (in shares)   (55,395)        
Prior year retained earnings 224       (8) 232
Balance, end of period at Jun. 30, 2018 23,390   (7) 37,786 0 (14,389)
Common stock, shares outstanding, ending (in shares) at Jun. 30, 2018   847,225,746        
Balance, beginning of period at Mar. 31, 2018 22,876   (7) 38,057 5 (15,179)
Common stock, shares outstanding, beginning (in shares) at Mar. 31, 2018   853,066,229        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 782         782
Other comprehensive loss 3       3  
Stock-based compensation 126     126    
Exercise of stock options 1     1    
Exercise of stock options (in shares)   59,106        
Stock issued for employee stock purchase plan (in shares)   (17)        
Issuance of vested restricted stock units (in shares)   508,554        
Shares withheld related to net share settlement of stock awards and stock options (10)     (10)    
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (167,907)        
Repurchases of common stock (388)     (388)    
Repurchases of common stock (in shares)   (6,240,219)        
Prior year retained earnings         (8) 8
Balance, end of period at Jun. 30, 2018 23,390   (7) 37,786 0 (14,389)
Common stock, shares outstanding, ending (in shares) at Jun. 30, 2018   847,225,746        
Balance, beginning of period at Dec. 31, 2018 $ 24,718   (6) 38,010 (332) (12,954)
Common stock, shares outstanding, beginning (in shares) at Dec. 31, 2018 850,180,317 850,180,317        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 1,847         1,847
Other comprehensive loss (481)       (481)  
Stock-based compensation 264     264    
Exercise of stock options 1     1    
Exercise of stock options (in shares)   51,135        
Stock issued for employee stock purchase plan 69     69    
Stock issued for employee stock purchase plan (in shares)   1,135,801        
Issuance of vested restricted stock units (in shares)   4,550,115        
Forfeiture of restricted stock awards (in shares)   (20,769)        
Shares withheld related to net share settlement of stock awards and stock options (104)     (104)    
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (1,420,662)        
Transfer RSU to NQDC plan     (2) 2    
Transfer RSU to NQDC plan (in shares)   (23,295)        
Prior year retained earnings 653         653
Balance, end of period at Jun. 30, 2019 $ 26,967   (8) 38,242 (813) (10,454)
Common stock, shares outstanding, ending (in shares) at Jun. 30, 2019 854,452,642 854,452,642        
Balance, beginning of period at Mar. 31, 2019 $ 26,181   (5) 38,100 (521) (11,393)
Common stock, shares outstanding, beginning (in shares) at Mar. 31, 2019   854,380,118        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 939         939
Other comprehensive loss (292)       (292)  
Stock-based compensation 143     143    
Exercise of stock options (in shares)   19,261        
Stock issued for employee stock purchase plan (in shares)   (36,710)        
Issuance of vested restricted stock units (in shares)   206,143        
Forfeiture of restricted stock awards (in shares)   (20,769)        
Shares withheld related to net share settlement of stock awards and stock options (4)     (4)    
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (56,041)        
Transfer RSU to NQDC plan     (3) 3    
Transfer RSU to NQDC plan (in shares)   (39,360)        
Balance, end of period at Jun. 30, 2019 $ 26,967   $ (8) $ 38,242 $ (813) $ (10,454)
Common stock, shares outstanding, ending (in shares) at Jun. 30, 2019 854,452,642 854,452,642